Breaking News

S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills

S.Korea authorises Novavax COVID-19 vaccine, imports Pfizer pills


A vial and sryinge are seen in front of a shown Novavax brand in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration

Register now for Absolutely free unrestricted accessibility to Reuters.com

SEOUL, Jan 12 (Reuters) – South Korea is turning to added pharmaceutical tools as it seems to be to pre-empt a surge of COVID-19 omicron bacterial infections, authorising the use of Novavax Inc’s vaccine on Wednesdayand preparing to distribute the very first of Pfizer’s antiviral products.

At minimum 21,000 of Pfizer’s (PFE.N) antiviral products, referred to as Paxlovid, will arrive in South Korea on Thursday, with an additional 10,000 far more predicted to get there by the finish of the month, the health and fitness ministry explained.

The pills, which had been authorised for emergency use in December, will start getting used in treatment plans for extra than 1,000 people per day commencing on Friday, the ministry extra

Sign up now for No cost unrestricted access to Reuters.com

“By priority, oral procedure is planned to start very first for patients aged 65 or older, or patients with lessened immunity at property and household treatment method centres,” a ministry spokesperson instructed a briefing.

Paxlovid was almost 90% helpful in avoiding hospitalizations and deaths in patients at high possibility of serious illness, in accordance to knowledge from the firm’s medical trial. Current lab info suggests the drug retains its efficiency from Omicron, Pfizer has stated. examine much more

South Korea’s foodstuff and drug safety ministry, meanwhile, introduced it experienced authorised the Novavax (NVAX.O) vaccine, which joins the ranks of earlier authorised vaccines produced by AstraZeneca Inc (AZN.L), Moderna Inc (AZN.L), Pfizer, and Johnson & Johnson’s (JNJ.N) Janssen.

South Korean vaccine developer SK Bioscience Co Ltd (302440.KS) claimed it will make the Novavax (NVAX.O) vaccine.

The two-dose, protein-centered vaccine has secured authorisations from European Union regulators and the Globe Wellbeing Organization. read a lot more

It has been authorised in India, Indonesia and the Philippines, where Novavax’s lover, Serum Institute of India, will provide it.

Novavax is awaiting acceptance in Japan, wherever its vaccine would be manufactured and distributed by Takeda Pharmaceutical (4502.T).

At least 84.2% of the country’s 52 million inhabitants have been fully vaccinated, even though 42.5%, have obtained booster pictures, according to well being officials.

South Korea added 4,388 new COVID-19 cases as of midnight Tuesday, for a complete of 674,868 circumstances and 6,166 deaths considering that the pandemic commenced, the Korea Disorder Manage and Avoidance Company (KDCA) claimed.

That number has dipped from all-time highs of almost 8,000 daily circumstances in mid-December, when authorities re-imposed strict social distancing measures to attempt to stem the tide.

Omicron only accounts for a portion of South Korea’s circumstances so much, but that percentage has risen to far more than 12.5% from 4% at the conclusion of December, well being officers mentioned on Wednesday.

Sign up now for Cost-free unrestricted access to Reuters.com

Reporting by Heekyong Yang, Joyce Lee, and Yeni Website positioning Writing by Josh Smith Editing by Clarence Fernandez

Our Criteria: The Thomson Reuters Trust Rules.



Source hyperlink